Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Video Interview: Novaseek Looks To Boost R&D Efficiency

This article was originally published in Scrip

Executive Summary

Novaseek Research CEO Kate Torchilin outlines to Emily Hayes, senior writer for Scrip's sister publication "The Pink Sheet," the key drivers behind development of her company's Novaseek Clinical Data Network for Research (CDNR) platform, which provides access to real-world clinical data and human bio specimens for use in trials. The tool processes clinical data in a way that is fully compliant with the Health Insurance Portability and Accountability Act. Researchers become knowledgeable about patients treated in US hospitals, helping to really inform their R&D programs and substantially improve on them, Torchilin explains.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst